---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-005384"
form_type: "8-K"
ticker: "NTRA"
cik: "0001604821"
company_name: "Natera, Inc."
filed_at: "2024-01-22T23:59:59+00:00"
generated_at: "2026-06-06T20:40:28.939754+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Natera acquires Invitae's prenatal and carrier screening assets for $10M upfront

## Summary
- Upfront cash payment of $10 million to Invitae for reproductive health assets.
- Additional potential milestone payments of $42.5 million, including cash and litigation-related credits.
- Invitae will transition its non-invasive prenatal screening and carrier screening customers to Natera.
- Acquisition expands Natera's cfDNA testing reach; CEO Steve Chapman cites commitment to service.

## SEC filing metadata
- accession: 0001104659-24-005384
- form_type: 8-K
- ticker: NTRA
- cik: 0001604821
- company_name: Natera, Inc.
- filed_at: 2024-01-22T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604821/000110465924005384/0001104659-24-005384-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604821/000110465924005384/tm243767d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-005384
- JSON: https://secwatch.observer/filing/0001104659-24-005384.json
- Plain text: https://secwatch.observer/filing/0001104659-24-005384.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.